Company
Lifordi Immunotherapeutics
| Industry | clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Lifordi Immunotherapeutics | Funding | 2025-11-19 |